Invest Clin 65(2): 134 - 142, 2024 https://doi.org/10.54817/IC.v65n2a01
Corresponding author: Jing Hao, Department of Traditional Chinese Medicine, Beijing Children’s Hospital, Capi-
tal Medical University, National Center for Children’s Health, No. 56 Nanlishi Road, West District, Beijing, China.
Tel: 010-59616363. E-mail:bchhaojing@163.com
Surgical complications in children with IgA
vasculitis: clinical analysis of 28 cases.
Jing Mu, Jing Hao, Xiaofang Zhen, Xin Mo, Yan Sheng
Department of Traditional Chinese Medicine, Beijing Children’s Hospital, Capital
Medical University, National Center for Children’s Health, Beijing,China.
Keywords: intussusception; intestinal perforation; Henoch-Schönlein purpura;
enterectomy; enterostomy; D-dimer; C-reactive protein.
Abstract. Intussusception and intestinal perforation are surgical severe
complications in children with IgA vasculitis (IgAV). Early diagnosis and timely
appropriate surgical intervention can reduce damage to the children. We an-
alyzed retrospectively the clinical characteristics, auxiliary examinations, di-
agnosis, treatment, and prognosis of 28 children with IgAV accompanied by
surgical complications (including intussusception in 21 patients and intesti-
nal perforation in seven patients) who were admitted to the Beijing Children’s
Hospital of the Capital Medical University from May 2016 to December 2020.
Within one year after the data was collected, the parents of the children were
interviewed by telephone about their treatment. Increased peripheral leuko-
cytes were observed in 60.7% of children. Serum C-reactive protein (CRP) and
D-dimer were elevated in 53.3% and 75% of children, respectively. Gastroin-
testinal bleeding was identified in 39% of children. Of the children with intus-
susception, the symptoms subsided spontaneously in four children and after air
enema in another four. Four children underwent laparotomy and manual reduc-
tion. Nine patients underwent enterectomy and anastomosis. Enterectomy and
anastomosis were performed in the seven patients with intestinal perforation,
two of whom underwent enterostomy concurrently. Increased inflammation in-
dexes, elevated D-dimer, and persistent abdominal pain without relief may be
risk factors for surgical complications in children with IgAV.
Surgical complications in children with IgA vasculitis 135
Vol. 65(2): 134 - 142, 2024
Complicaciones quirúrgicas en niños con vasculitis IgA:
análisis clínico de 28 casos.
Invest Clin 2024; 65 (2): 134 – 142
Palabras clave: intususcepción; perforación intestinal; púrpura de Henoch-Schönlein;
enterectomía; enterostomía; dímero D; proteína C-reactiva.
Resumen. La intususcepción y la perforación intestinal son complicacio-
nes quirúrgicas graves en niños con vasculitis por IgA (IgAV). El diagnóstico
temprano y la intervención quirúrgica adecuada y oportuna pueden reducir el
daño de esta enfermedad a los niños. Analizamos retrospectivamente las carac-
terísticas clínicas, exámenes auxiliares, diagnóstico, tratamiento y pronóstico
de 28 niños con IgAV acompañada de complicaciones quirúrgicas (incluida in-
tususcepción en 21 pacientes y perforación intestinal en siete pacientes) que
ingresaron en el Hospital Infantil de Beijing de la Universidad Médica de la Ca-
pital, de mayo de 2016 a diciembre de 2020. Un año después de la recopilación
de datos, los padres de los niños fueron entrevistados telefónicamente sobre su
tratamiento. Se observó un aumento de leucocitos periféricos en el 60,7% de
los niños. La proteína C reactiva (PCR) y el dímero D séricos estaban elevados
en el 53,3% y el 75% de los niños, respectivamente. Se identificó hemorragia
gastrointestinal en el 39% de los niños. De los niños con intususcepción, los sín-
tomas desaparecieron espontáneamente en cuatro niños y después de un enema
de aire en otros cuatro. Cuatro niños fueron sometidos a laparotomía y reduc-
ción manual. Nueve pacientes fueron sometidos a enterectomía y anastomosis.
Se realizó enterectomía y anastomosis en los siete pacientes con perforación
intestinal, dos de los cuales fueron sometidos a enterostomía al mismo tiempo.
El aumento del índice de inflamación, el dímero D elevado y el dolor abdominal
persistente sin alivio pueden ser factores de riesgo de complicaciones quirúrgi-
cas en niños con IgAV.
Received: 20-01-2023 Accepted: 18-03-2024
INTRODUCTION
IgA Vasculitis (IgAV), formerly known
as Henoch-Schönlein purpura (HSP), is a sys-
temic small vasculitis syndrome that usually
occurs in children. In 1802, Heberden first
described this syndrome. He reported a child
with joint pain and subcutaneous edema, ab-
dominal pain, vomiting, blood in the stool
and blood in the urine, as well as “blood
spots” on the skin of the legs
1
. Initially,
Schönlein used the term “rheumatic purpu-
ra” to describe the association between joint
pain and purpuric skin lesions in children.
In 1874, Henoch described the syndrome of
purpura, severe abdominal cramps, and me-
lena. Later, Henoch referred to nephritis as
a complication of the syndrome
2
.
The disease can cause purpuric skin le-
sions and is accompanied by various symp-
toms, including gastrointestinal symptoms,
arthritis, and nephritis. Approximately 50%
136 Mu et al.
Investigación Clínica 65(2): 2024
to 75% of IgAV children present with gastro-
intestinal symptoms, such as abdominal pain
3
with various degrees, from mild abdominal
pain to severe intestinal colic. Some children
may have serious surgical complications, in-
cluding intussusception, intestinal perfora-
tion, intestinal necrosis, intestinal obstruc-
tion, significant gastrointestinal bleeding,
severe pancreatitis, and testicular torsion.
Delayed management and surgical interven-
tion are associated with serious consequenc-
es and even death. We should carefully watch
for surgical complications in children with
severe abdominal pain and gastrointestinal
bleeding. Complete examinations should be
performed promptly to identify early com-
plications, such as intussusception and in-
testinal perforation. Appropriate and timely
treatment should be given accordingly. There
are many reports on the use of corticoste-
roids and immunosuppressive drugs
1
. These
specific treatments are still controversial,
and their efficacy remains to be evaluated.
If the complications are severe, including se-
vere gastrointestinal complications or prolif-
erative glomerulonephritis, steroids or/and
immunosuppressive drugs may be needed,
including colchicine, dapsone, montelukast,
corticosteroids and azathioprine and other
drugs
4-6
.
There have been relatively few clinical
and epidemiological studies on childhood
HSP in the past few years. To investigate this
syndrome further, we retrospectively ana-
lyzed the clinical data of 28 children with
intussusception or intestinal perforation
among 7374 children with IgAV.
METHODS
From May 2016 to May 2020, 7374
children with IgAV were treated in the De-
partment of Traditional Chinese Medicine,
Beijing Children’s Hospital, Capital Medi-
cal University. Surgical complications were
reported in 28 children, including intussus-
ception in 21 children and intestinal perfo-
ration in seven children. We retrospectively
analyzed the clinical characteristics, aux-
iliary examinations, diagnosis, treatment,
and prognosis of all 28 children with IgAV.
All data were collected from our Hospital’s
electronic medical record system.
Inclusion criteria
Patients with primary cutaneous vascu-
litis were classified as HSP or allergic vascu-
litis
2
, according to the American College of
Rheumatology (ACR) standards and the stan-
dards proposed by Michel et al. If the patient
met the following three or more criteria, the
patients were classified as HSP: 1) palpable
purpura, 2) intestinal colic, 3) gastrointes-
tinal bleeding, 4) hematuria (macroscopic
or microscopic hematuria), 5) disease onset
age 20 years, and 6) there was no history
of drug treatment before the onset of vascu-
litis. Patients who met less than three cri-
teria were classified as allergic vasculitis. In
addition, if children were diagnosed with pri-
mary skin vasculitis or other diseases, such
as connective tissue diseases and infections,
especially meningitis
7
, they were excluded
from the study. Because electronic medical
records have only been used recently in our
Hospital, only no more than three years of
medical records were collected. The inci-
dence of IgA vasculitis with surgical com-
plications is not high, so only 28 cases were
collected. A pre-existing anatomical factor
as the starting point of the invagination, an
accidental finding, and where the intussus-
ception was spotted in such cases as to be
taken as criteria for inclusion or exclusion.
Treatment methods
Surgical treatment: Of the 21 children
with intussusception, the symptoms subsid-
ed spontaneously in four children and after
air enema in four. Four children underwent
laparotomy and manual reduction. Nine
patients underwent enterectomy and anas-
tomosis due to intestinal necrosis (one of
them underwent enterostomy). Enterecto-
my and anastomosis were performed in the
seven patients with intestinal perforation
Surgical complications in children with IgA vasculitis 137
Vol. 65(2): 134 - 142, 2024
(two of them underwent enterostomy con-
currently).
Conservative treatment methods: Ac-
cording to the specific conditions of the
children, the children were treated with fast-
ing, gastrointestinal decompression, enteral
or parenteral nutrition support, glucocor-
ticoids, proton pump inhibitors, or gamma
globulin, as needed.
Follow up
During the follow-up of all 28 children,
three children had adhesive intestinal ob-
struction and underwent secondary surgery.
Four children had multiple hospitalizations
due to IgAV nephritis, and one child was re-
admitted due to abdominal pain.
Statistical analysis
The data are expressed as mean ± stan-
dard deviation. The differences between the
groups were analyzed using the chi-square
test. P<0.05 was considered statistically sig-
nificant. All statistical analysis is performed
using SPSS software (SPSS 19, IBM, USA).
RESULTS
General data
Twenty-eight of the 7,374 children with
IgAV were accompanied by surgical compli-
cations, a rate of 0.38%. Twenty-one children
had intussusception, and seven children had
intestinal perforation. Of the 28 children, 10
were males and 18 were females. The age at
onset ranged from 3 to 13 years (mean age:
7.2 years). The time from onset of purpura to
occurrence of surgical complications ranged
from 1 to 37 days (mean: 11 days), and the
time from onset of abdominal pain to occur-
rence of surgical complications ranged from
1 to 40 days (mean: 9.8 days). Of these pa-
tients, 6 (6/28) children complained of ab-
dominal pain before purpura appeared.
Clinical manifestations
All 28 children had symptoms of skin
purpura. Seven children (7/28) had joint
swelling and pain, 11 (11/28) had gastroin-
testinal bleeding, and five (5/28) had IgAV
nephritis (two cases with nephrotic syndrome
and three cases with hematuria and protein-
uria). All patients presented with apparent
abdominal pain. Tenderness and rebound ten-
derness were noted on abdominal examina-
tion. An abdominal mass was palpated in four
patients. The severity of the complications
in patients was different, and four patients
developed shock (hemorrhagic shock in one
patient and septic shock in three patients).
Convulsions occurred in two children (due to
IgAV involving the cerebrovascular system).
Three patients were complicated with pneu-
monia. After surgery, venous thrombosis oc-
curred in three patients, renal dysfunction
in one patient, pancreatic damage in one pa-
tient, thrombocytopenia in one patient, and
coagulation disorders in one patient.
Auxiliary examination
A routine blood count showed increased
leukocyte count in 17 children (17/28), with
the highest value being 33.11 × 10
9
/L (nor-
mal range: 4-10×10
9
/L). Elevated CRP was
noted in 15 children (15/28), with the high-
est value being > 160 mg/L (average value
< 8 mg/L). Elevated D-dimer was noted in
21 children (21/28), with the highest value
being 7.565 mg/L (normal limits: 0-0.243
mg/L). Four children tested positive in the
13
C-urea breath test. Serum influenza B virus
IgM was positive in six children. Serum in-
fluenza A virus IgM was positive in two chil-
dren. Serum mycoplasma pneumoniae IgM
was positive in two children. According to
abdominal B-mode ultrasonography or surgi-
cal exploration in some patients, 12 children
were diagnosed with ileo-ileal intussuscep-
tion, six children with ileo-colonic intussus-
ception, two children with jejunal-jejunal
intussusception, and one child with colon-
colonic intussusception. Of the seven chil-
dren with intestinal perforations, six were
diagnosed with ileal perforation (including
a child accompanied by colonic perforation)
and a child with jejunal perforation.
138 Mu et al.
Investigación Clínica 65(2): 2024
DISCUSSION
IgAV is a common small-blood-vessel al-
lergic disease occurring during childhood; it
is most common in children aged three to
eight years
8
, with a predominance in males.
Skin purpura is most commonly accompanied
by digestive tract, joint, or kidney lesions. Ab-
dominal symptoms are reported in 50% to
75% of IgAV children, including gastrointesti-
nal bleeding, gastric ulcers, pancreatitis, cys-
tic effusion, and protein-losing enteropathy.
Some rare surgical complications include in-
tussusception, intestinal obstruction, intesti-
nal fistula, and intestinal perforation
3,9
.
Intussusception is the most common
condition for surgery in IgAV children, with
an incidence of 3% to 4%
10
. Intestinal per-
foration is the second-leading condition for
surgery, with an incidence of approximately
0.38%
11
. In the past three years, we have
treated 7,374 patients with IgAV; surgical
complications were reported in 28 patients.
The incidence of intussusception was 0.28%,
and the incidence of intestinal perforations
was 0.09%. Due to our Hospital’s late use of
electronic medical records, no more than
three years of case data have been counted.
If the statistical years were longer, the data
may be more meaningful. The pathogenesis
of intussusception may be due to the aseptic
inflammation of small blood vessels in the
intestinal wall, which increases the perme-
ability of the intestinal wall blood vessels
10,12
to result in extravasation of blood com-
ponents and segmental bleeding under the
serosa and mucosa. These lead to uneven
peristaltic movement, local slow peristalsis,
spasms of the intestinal loop, or even intus-
susception
13
.As the disease progresses, tis-
sue hypoxia and hypoperfusion may occur.
Intestinal wall edema, ischemia, and hypoxia
lead to intestinal necrosis and even intesti-
nal perforation
14
. In the acute phase of IgAV,
increased blood viscosity results in slow lo-
cal blood flow and exacerbates intestinal
ischemia and hypoxia.The circulating D-di-
mer level in children with IgAV is significant-
ly increased
15
. This reflects the presence of
hypercoagulable states and the formation of
thrombi. Another study
16
found that IgAV
caused a significant increase in serum CRP
in children with abdominal surgical compli-
cations, suggesting that the occurrence of
this complication may be closely related to
infectious factors. Furthermore, serum CRP
level has been positively correlated with the
occurrence of these complications. This fur-
ther indicates that infectious factors play
an essential role in the occurrence of surgi-
cal complications.We summarized the clini-
cal data of all 28 children in this study and
found that the average time from the onset
of abdominal pain to the first surgical com-
plication was 9.8 days, and the longest time
was 40 days. Increased peripheral leukocyte
count was observed in 60.7% of children. Se-
rum CRP and D-dimer levels were elevated
in 53.3% and 75% of children, respectively.
Gastrointestinal bleeding was identified in
39%. Increased inflammation index, elevat-
ed D-dimer, and persistent abdominal pain
without relief may be risk factors for surgical
complications in children with IgAV. For this
child population, we should carefully watch
for surgical complications. Early and precise
diagnosis and timely, appropriate treatment
can reduce the harm to these children.
Intussusception in IgAV patients usu-
ally originates from the ileum (90%) or jeju-
num (7%)
17
. The common sites of intussus-
ception are ileo-ileal (51.4%), ileo-colonic
(38.6%), and jejunal-jejunal (7.0%). In IgAV,
colo-colonic intussusception is extremely
rare, with only a few cases reported
16
. The
most common site of intestinal perforation
is the small intestine, especially the ileum,
followed by the jejunum. This may be due
to the intestinal wall swelling in the small
intestine in IgAV patients. Children with
IgAV also often have infection, which can
enlarge the aggregated lymphoid nodules
in the ileum. Therefore, the local intestinal
wall thickens and even protrudes into the
intestinal lumen to form a starting point of
intussusception
18
. Among the children with
Surgical complications in children with IgA vasculitis 139
Vol. 65(2): 134 - 142, 2024
intussusception in this study, ileo-ileal intus-
susception, ileum-colonic intussusception,
and jejunal-jejunal intussusception made up
57%, 28%, and 9.5% of all intussusceptions,
respectively. Colo-colonic intussusception
was seen in one patient. Of the seven chil-
dren with intestinal perforation, six had ileal
perforation, and one had jejunal perforation.
The incidence ofintestinal perforation is ba-
sically consistent with that in the literature.
Some researchers have suggested
19
that
air enema is the best reduction treatment for
IgAV-related early intussusception. Air enema
is minimally traumatic to children and can be
done more than once. It is difficult to differen-
tiate the abdominal pain caused by IgAV from
the abdominal pain caused by complicated in-
tussusception in IgAV because of certain simi-
larities in the symptoms. Intussusception that
occurs based on intestinal bleeding and edema
is associated with rapid progression and in-
testinal necrosis. On the other hand, ileo-ileal
intussusception is the most common kind, in
which the failure rate and recurrence rate of air
enema reduction is higher. This study relieved
intussusception only in four children after air
enema.
Children with IgAV-related surgical condi-
tions may develop serious and even life-threat-
ening complications. In this study, shock was
reported in four children (hemorrhagic shock
in one patient and septic shock in three pa-
tients), postoperative venous thrombosis in
three patients, renal insufficiency in one pa-
tient, coagulation disorders in one patient, and
adhesion intestinal obstruction in three pa-
tients, which required secondary surgery later.
Therefore, we should improve our understand-
ing of IgAV-related surgical complications to
make early diagnoses and provide the appropri-
ate surgical intervention.
The use of glucocorticoids for the treat-
ment of IgAV has been controversial. Some
researchers have suggested that early use of
glucocorticoids can significantly relieve ab-
dominal pain and reduce the risk of kidney
disease
20
. It can reduce the incidence
21
or
prevent intussusception
22
. Other research-
ers disagree
10,23
. The use of glucocorticoids
in patients with IgAV complicated with in-
tussusception may mask the symptoms of
intestinal perforation or aggravate the intus-
susception
24
. Foreign studies have reported
that IgAV-related intestinal perforation usu-
ally occurs two weeks after the application
of glucocorticoids
6
. In this study, all 21 chil-
dren with intussusception were treated with
glucocorticoids, and some were treated with
gamma globulin. The children’s abdominal
pain and purpura were alleviated. Of the sev-
en children with intestinal perforation in this
study, four had been taking glucocorticoids
for more than 20 days, and three of them de-
veloped severe infections with septic shock.
Therefore, the dosage and timing of gluco-
corticoids need to be further explored. How-
ever, it draws attention that from May 2016
to 2020, there is a registry of patients in the
pediatric population that are diagnosed with
IgA vasculitis (7,374 children), and none
of the reports state that the diagnosis was
confirmed through biopsies of white organs.
There are a fair amount of cases (it is because
the Hospital is a reference area, or the data
collected is national or local); they may also
have other pathologies that could be present-
ed through a similar clinical picture, which
would explain the large population reported.
The risk-benefit of a steroid treatment prior
to the appearance of surgical complications
cannot be assessed in this work.
Due to the limited study funding and
time, the deficiency of this study is the fail-
ure to collect the characteristics of each
case (onset, relevant laboratory tests, treat-
ment time before symptoms and signs, lapa-
rotomy results, air enema treatment, etc.).
Moreover, a range of examinations evaluate
the inflammatory response (CB, PCR, Dimer
D), and the predictive value and prognostic
value cannot be established with this work.
Our team will conduct the study in the fu-
ture. Meanwhile, a better collection of clini-
cal, laboratory, and imaging data is needed
to establish prognostic value in patients with
said pathology.
140 Mu et al.
Investigación Clínica 65(2): 2024
Table 1
Clinical data of the 28 children with Henoch-Schönlein purpura accompanied by surgical complications.
Number Joint swelling
and pain
Gastrointes-
tinal bleeding
Kidney
damage
Surgical
complications
Site Surgical
treatments
Other
comorbidities
Reason for
rehospitalization
1 + + Intussusception Ileo-ileal Air enema IgAV nephritis
2 + + Intussusception Ileo-ileal Enterectomy and anastomosis
3 + + Intussusception Ileum-colon Open laparotomy and manual reduction Venous thrombosis
4 Intussusception Ileo-ileal N/A pneumonia
5 + + Intussusception Ileo-ileal Enterectomy and anastomosis Hemorrhagic shock, Pneumonia,
Coagulation disorders
IgAV nephritis
6 + Intussusception Ileo-ileal Open laparotomy and manual reduction
7 Intussusception Jejunum-jejunum N/A
8 + Intussusception Ileo-ileal Enterectomy and anastomosis Intestinal obstruction
9 + Intussusception Ileo-ileal N/A IgAV nephritis
10 + Intussusception Ileum-colon Air enema
11 Intussusception Ileo-ileal Enterectomy and anastomosis
12 Intussusception Ileo-ileal Open laparotomy and manual reduction
13 + + Intussusception Ileum-colon Enterectomy and anastomosis
14 Intussusception Ileum-colon Open laparotomy and manual reduction
15 + Intussusception Ileo-ileal Enterectomy and anastomosis
16 + Intussusception Ileum-colon Air enema IgAV
17 Intussusception Jejunal-jejunal Enterectomy and anastomosis
18 + + Intussusception Colono-colonic Air enema Pneumonia
19 + Intussusception Ileo-ileal Enterectomy and anastomosis Pancreatic damage Intestinal obstruction
20 Intussusception Ileo-ileal Enterectomy and anastomosis + enterostomy
21 Intussusception Ileum-colon N/A
22 Intestinal perforation Ileum Enterectomy and anastomosis Intestinal obstruction
23 Intestinal perforation Ileum, colon Enterectomy and anastomosis + enterostomy Septic shock, renal insufficiency,
Convulsions
24 Intestinal perforation Ileum Enterectomy and anastomosis septic shock, Convulsions, Venous
thrombosis
25 + Intestinal perforation jejunum Enterectomy and anastomosis Septic shock, Venous thrombosis,
Thrombocytopenia
26 + Intestinal perforation Ileum Enterectomy and anastomosis
27 Intestinal perforation Ileum Enterectomy and anastomosis
28 + Intestinal perforation Ileum Enterectomy and anastomosis + enterostomy IgAV nephritis
Surgical complications in children with IgA vasculitis 141
Vol. 65(2): 134 - 142, 2024
As a conclusion, intussusception and in-
testinal perforation are serious surgical com-
plications of IgAV. Clinicians should make an
effort to understand IgAV-related surgical
complications. Once specific symptoms are
present, including increased inflammation
index, elevated D-dimer, persistent abdomi-
nal pain without relief, and digestive tract
hemorrhage or previously existing intestinal
malformations, we should observe for sur-
gical complications and make a clear diag-
nosis as soon as possible. Appropriate and
timely surgical intervention can avoid de-
layed treatment and reduce mortality.
Ethics approval and consent to participate
All procedures performed in studies
involving human participants followed the
ethical standards of the Independent Ethics
Committee for Clinical Research and Ani-
mal Trials of the Beijing Children’s Hospital,
Capital Medical University, and the National
Center for Children’s Health. Informed con-
sent was obtained from all individual partici-
pants included in the study.
Funding
This study was supported by Yan Huimin
National Famous Traditional Chinese Medi-
cine Experts Inheritance Studio Traditional
Chinese Medicine Education [2016] No. 42.
Conflict of interest
The authors state that no financial,
personal, or professional conflicts of interest
may hinder this work.
Authors’ ORCID
Jing Mu (JM):
0000-0001-5542-8838
Jing Hao (JH):
0000-0002-0260-1841
Xiaofang Zhen (XZ):
0000-0001-8781-9999
Xin Mo (XM):
0009-0004-5510-0508
Yan Sheng (YS):
0009-0009-2075-6036
Authors’ contributions
JM, JH, XFZ, and XM performed mate-
rial preparation, data collection, and analy-
sis. JM and YS wrote the first draft of the
manuscript, and all authors commented on
previous versions. All authors read and ap-
proved the final manuscript.
REFERENCES
1. Audemard-Verger A, Pillebout E, Guille-
vin L, Thervet E, Terrier B. IgA vasculi-
tis (Henoch-Shonlein purpura) in adults:
Diagnostic and therapeutic aspects. Au
-
toimmun Rev 2015; 14(7):579-585.
2. Calviño MC, Llorca J, Garcia-Porrua C,
Fernandez-Iglesias JL, Rodriguez-Ledo P,
Gonzalez-Gay MA. Henoch-Schönlein Pur
-
pura in Children from Northwestern Spain:
A 20-Year Epidemiologic and Clinical Stu
-
dy. Medicine 2001; 80(5): 279-290.
3. Fatima A, Gibson DP. Pneumatosis intes
-
tinalis associated with Henoch-Schonlein
purpura. Pediatrics 2014; 134(3):e880-
883.
4. Bar-Eli M, Wilson L, Peters RS, Schwa
-
be AD, Territo MC. Microtubules in PMNs
from patients with familial Mediterranean
fever. Am J Med Sci 1982; 284(2):2-7.
5. Harper RM, Allen BS. Use of colchicine
in the treatment of Behcet
s disease. Int J
Dermatol 1982; 21(9):551-554.
6. Saatci U, Ozen S, Ozdemir S, Bakkaloglu
A, Besbas N, Topaloglu R, Arslan S. Fami
-
lial Mediterranean fever in children: report
of a large series and discussion of the risk
and prognostic factors of amyloidosis. Eur
J Pediatr 1997; 156(8):619-623.
7. Fiechtner J, Ito S, Nakano M, Gejyo F,
Hanyu T, Murasawa A. Thoughts on Japa
-
nese versus North American rheumatology.
J Clin Rheumatol 2001; 7(3):208-209.
142 Mu et al.
Investigación Clínica 65(2): 2024
8. Rostoker G. Schonlein-Henoch purpura in
children and adults: diagnosis, pathophy
-
siology and management. BioDrugs 2001;
15(2):99-138.
9. Yang X, Duan Y, Zhou C, Jin L, Zhang N,
Huang S, Zhang M, Yang J, Zhang Y. Pri
-
mary central nervous system lymphoblastic
B cell lymphoma located at cerebellum in
a child: A case report and literature review.
Pediatr Investig. 2021 Dec 13;5(4):318-
322. doi: 10.1002/ped4.12303.
10. Trnka P. Henoch-Schonlein purpura in
children. J Paediatr Child Health 2013;
49(12):995-1003.
11. Brown PJ, Haught JM, English JC. Pe
-
riumbilical purpura prior to gastrointes-
tinal involvement in Henoch-Schonlein
purpura. Am J Clin Dermatol 2009;
10(2):127-130.
12. Zhang R, Du G, Sun F. Clinical ananlysis
on Henoch-Schonlein purpura accompa
-
nied with intussusception. J Clin Pediatr
Surg 2014; 13(6):540-542.
13. Yavuz H, Arslan A. Henoch-Schonlein
purpura-related intestinal perforation: a
steroid complication?Pediatr Int 2001;
43(4):423-425.
14. Liu G, Dong K, Shen C. Management of
severe abdominal purpura with surgical
complications. Chin J Pediatr Surg 2012;
33(12):905-908.
15. Guo K, Ma S, Wang D. Evaluation and
comparison of thromboelastography and
conventional coagulation tests for blood
coagulation function in children with He
-
noch-Schönlein purpura. China Journal of
Leprosy and Skin Dis 2019; 27(3):327-329.
16. Li B, Yan B, Da Y. Shen Y, Li G, Li L. The
changes of serum procalcitonin, interleu
-
kin-6 and C reactive protein in children
with Henoch-Schönlein purpura combi
-
ned with surgical complications. J Clin
Pediatr 2014; 32(7): 660. doi:10.3969
j.issn.1000-3606.2014.07.016.
17. Seo MK , Hong J, Yim HE, Pai KS. A pa
-
tient with Henoch-Schönlein purpura with
intussusception and intractable nephritis.
Child Kidney Dis 2016; 20(2):92-96.
18. Wang C, Di Z. Analysis of diagnosis and
treatment of Henoch-Schönlein purpura
with intussusception in children. China
Journal of Leprosy and Skin Dis 2018;
34(6):327-329.
19. Matsui S, Kanemura T, Yokouchi Y, Ka
-
miichi H, Kiriu N, Koike Y. Successful
treatment of ileocolic intussusception
with air enema reduction in an adult pa
-
tient. Am J Emerg Med 2014; 32(5):490
e491-493.
20. Lerkvaleekul B, Treepongkaruna S, Sai
-
sawat P, Thanachatchairattana P, An-
gkathunyakul N, Ruangwattanapaisarn
N, Vilaiyuk S. Henoch-Schonlein purpura
from vasculitis to intestinal perforation: A
case report and literature review. World J
Gastroenterol 2016; 22(26):6089-6094.
21. Huber AM, King J, McLaine P, Klassen
T, Pothos M. A randomized, placebo-con
-
trolled trial of prednisone in early Henoch
Schonlein purpura [ISRCTN85109383].
BMC Med 2004; 2:7.
22. Shimoyama T, Matsuda N, Kurobe M,
Hayakawa T, Nishioka M, Shimohira
M, Takasawa K. Colonoscopic diagnosis
and reduction of recurrent intussuscep
-
tion owing to Henoch-Schonlein purpura
without purpura. Paediatr Int Child Health
2019; 39(3):219-223.
23. Blumen J, Goldman RD. Henoch-Schön
-
lein purpura in children: limited benefit of
corticosteroids. Can Fam Physician 2014;
60(11):1007-1010.
24. Krishnan M, Nahas J. Adult onset Henoch-
Schonlein purpura and intussusception: a
rare presentation. Case Rep Rheumatol
2016; 2016:3957605.